<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28032" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pulmonary Hemorrhage</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shee</surname>
            <given-names>Brian</given-names>
          </name>
          <aff>Coney Island Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Anjum</surname>
            <given-names>Fatima</given-names>
          </name>
          <aff>Temple University, Lewis Katz School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharma</surname>
            <given-names>Sanjeev</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rockoff</surname>
            <given-names>Bradley I.</given-names>
          </name>
          <aff>Coney Island Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Brian Shee declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Fatima Anjum declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sanjeev Sharma declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bradley Rockoff declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>8</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28032.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Pulmonary hemorrhage presents a critical challenge in respiratory medicine, often manifesting as hemoptysis across a spectrum of respiratory diseases such as bronchiectasis, tumors, tuberculosis, aspergilloma, and cystic fibrosis. Hemoptysis refers to the expectoration of blood, either alone or mixed with mucus, originating from the lower respiratory tract (below the vocal cords). The severity of hemoptysis varies widely, ranging from mild to life-threatening, potentially leading to hemodynamic instability and fatal outcomes due to suffocation or shock. Clinically categorizing pulmonary hemorrhage by "magnitude and effect" may offer more practical utility. Given its high mortality rate (up to 70% before the use of bronchial artery embolization), approaching pulmonary hemorrhage requires rapid evaluation, stabilization, and definitive care, including determining the source of bleeding and appropriate management strategies such as airway protection, oxygenation, ventilation, and imaging for definitive intervention.</p>
        <p>Clinicians participating in this course gain a comprehensive understanding of the etiology, diagnosis, and management of pulmonary hemorrhage. The course covers the latest diagnostic techniques, including endoscopic and radiographic methods, and treatment options like bronchial artery embolization and surgical interventions. Additionally, participants learn best practices for interprofessional communication and care coordination to enhance patient outcomes and safety. Collaboration with an interprofessional team is essential in managing complex cases of pulmonary hemorrhage, as it allows for a multidisciplinary approach that leverages the expertise of various healthcare professionals.&#x000a0;</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the underlying causes of pulmonary hemorrhage, including bronchiectasis, tumors, tuberculosis, aspergilloma, and cystic fibrosis, through thorough patient history-taking, physical examination, and appropriate diagnostic tests.</p></list-item><list-item><p>Differentiate between mild and life-threatening cases of hemoptysis to prioritize prompt and appropriate management strategies, considering factors such as hemodynamic stability and risk of fatal outcomes.</p></list-item><list-item><p>Implement evidence-based treatment modalities for pulmonary hemorrhage, such as bronchial artery embolization and surgical interventions, in a timely and coordinated manner to optimize patient outcomes.</p></list-item><list-item><p>Collaborate with interprofessional teams to develop comprehensive care plans and ensure seamless transitions of care for patients with pulmonary hemorrhage.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28032&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28032">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-28032.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Pulmonary hemorrhage presents a critical challenge in respiratory medicine, often manifesting as hemoptysis across a spectrum of respiratory diseases such as bronchiectasis, tumors, tuberculosis, aspergilloma, and cystic fibrosis. Hemoptysis refers to the expectoration of blood, either alone or mixed with mucus, originating from the lower respiratory tract (below the vocal cords). The severity of hemoptysis varies widely, ranging from mild to life-threatening, potentially leading to hemodynamic instability and fatal outcomes due to suffocation or shock.<xref ref-type="bibr" rid="article-28032.r1">[1]</xref>&#x000a0;</p>
        <p>Pulmonary hemorrhage primarily involves bleeding from the pulmonary or bronchial vasculature, typically from the higher-pressure bronchial system.<xref ref-type="bibr" rid="article-28032.r2">[2]</xref> Previous classifications of pulmonary hemorrhage focused on quantifying blood loss, which can be difficult.<xref ref-type="bibr" rid="article-28032.r2">[2]</xref> Clinically, categorizing pulmonary hemorrhage by "magnitude and effect" may offer more practical utility.<xref ref-type="bibr" rid="article-28032.r2">[2]</xref> Given its high mortality rate (up to 70% before the use of bronchial artery embolization), approaching pulmonary hemorrhage requires rapid evaluation, stabilization, and definitive care&#x02014;including determining the source of bleeding and appropriate management strategies such as airway protection, oxygenation, ventilation, and imaging for definitive intervention.<xref ref-type="bibr" rid="article-28032.r2">[2]</xref><xref ref-type="bibr" rid="article-28032.r3">[3]</xref></p>
      </sec>
      <sec id="article-28032.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The usual source of massive pulmonary hemorrhage is the bronchial vasculature. This high-pressure system is responsible for up to 90% of massive hemoptysis.<xref ref-type="bibr" rid="article-28032.r2">[2]</xref> Other sources include aortobronchial fistulas, ruptured aneurysms, nonbronchial sources (5%), and pulmonary vessels (5%).</p>
        <p>Based on the results from a retrospective cohort study of 1087 patients at a single tertiary hospital in France, the most common causes of massive pulmonary hemorrhage are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Tuberculosis (25%; with active responsible for 12% and sequelae 13%)</p>
          </list-item>
          <list-item>
            <p>Bronchiectasis (20%)</p>
          </list-item>
          <list-item>
            <p>Mycetomas (6%)</p>
          </list-item>
          <list-item>
            <p>Cryptogenic hemoptysis (18%)</p>
          </list-item>
          <list-item>
            <p>Bronchogenic carcinomas (17%)&#x000a0;<xref ref-type="bibr" rid="article-28032.r4">[4]</xref><xref ref-type="bibr" rid="article-28032.r1">[1]</xref></p>
          </list-item>
          <list-item>
            <p>Other sources: Trauma and iatrogenic</p>
          </list-item>
        </list>
        <p>Results from a more recent prospective Italian study of 606 patients from&#x000a0;5 Italian hospitals showed the most common causes to be:</p>
        <list list-type="bullet">
          <list-item>
            <p>Lung cancer&#x000a0;(19.1%)</p>
          </list-item>
          <list-item>
            <p>Pneumonia/lung abscess&#x000a0;(18.6%)</p>
          </list-item>
          <list-item>
            <p>Bronchiectasis (14.9%)</p>
          </list-item>
          <list-item>
            <p>Acute bronchitis (13.7%)</p>
          </list-item>
          <list-item>
            <p>Tubercluosis (5%; active [3.3%] and sequelae [1.7%])&#x000a0;<xref ref-type="bibr" rid="article-28032.r5">[5]</xref></p>
          </list-item>
        </list>
        <p>In a Greek study, results showed that bronchiectasis and neoplasms are the leading cause of moderate-to-severe&#x000a0;pulmonary hemorrhage (moderate defined as 20-500 mL in 24 hours; severe defined as more significant than 500 mL in 24 hrs).<xref ref-type="bibr" rid="article-28032.r6">[6]</xref></p>
      </sec>
      <sec id="article-28032.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Hemoptysis, coughing up blood from the respiratory tract, presents varied epidemiological patterns influenced by underlying conditions and geographic factors. A symptom rather than a disease is commonly associated with respiratory infections, chronic lung diseases, and malignancies. Hemoptysis generally involves minimal bleeding, often linked to inflammatory or infectious causes, usually amounting to less than 100 mL of blood over 24 hours. Although massive hemoptysis is rare, accounting for 5% to 15% of cases, it is a life-threatening condition that requires immediate and effective assessment and management. The definition of massive hemoptysis varies widely in the literature, with previous descriptions ranging from more than 200 mL to over 1000 mL of blood within 24 hours.<xref ref-type="bibr" rid="article-28032.r7">[7]</xref></p>
        <p>The prevalence and incidence of hemoptysis vary widely across different regions and populations, with higher rates often observed in areas with a high burden of tuberculosis (TB), bronchiectasis, and lung cancer. In developed countries, chronic bronchitis and bronchiectasis significantly contribute to hemoptysis, whereas TB remains a prominent cause in developing regions. Epidemiological studies indicate a bimodal distribution, with peaks in younger adults due to infections like&#x000a0;TB and in older adults due to malignancies such as lung cancer.&#x000a0;In a single-center French study, the median age was 54; 71% of the patients were men, and a smoking history was&#x000a0;present in 71% of the patients. The study by Mondoni et al showed a median age of 67, 66.7% of the patients were men, and a smoking history was present in 54% of the patients.<xref ref-type="bibr" rid="article-28032.r5">[5]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-28032.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of various conditions is described below:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Tuberculosis</bold>
<list list-type="bullet"><list-item><p>During active TB, bleeding is usually a result of ulcerations with subsequent necrosis of adjacent vessels.<xref ref-type="bibr" rid="article-28032.r8">[8]</xref> In patients with a history of TB, it is often a consequence of the erosion of a calcified lymph node into a vessel and trachea, bronchiectasis secondary to the prior infection, or fungal infection in a cavity left from an earlier infection.<xref ref-type="bibr" rid="article-28032.r9">[9]</xref>&#x000a0;While the offending vessel is usually one of the bronchial arteries, a rupture of a Rasmussen aneurysm may occasionally come off the pulmonary artery circulation.<xref ref-type="bibr" rid="article-28032.r10">[10]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Bronchiectasis</bold>
<list list-type="bullet"><list-item><p>This includes rupture of the tortuous vessels and hypertrophy due to chronic inflammation in the bronchial arterial system and blood vessels in the peribronchial and submucosal plexus.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Mycetomas</bold>
<list list-type="bullet"><list-item><p>The most common organism responsible for this condition is <italic toggle="yes">Aspergillus fumigatus</italic> (50%-90%), which is known to cause vascular and parenchymal changes in infection.<xref ref-type="bibr" rid="article-28032.r8">[8]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Smoking</bold>
<list list-type="bullet"><list-item><p>Cryptogenic bleeding tends to occur in smokers.<xref ref-type="bibr" rid="article-28032.r11">[11]</xref><xref ref-type="bibr" rid="article-28032.r12">[12]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Carcinoma</bold>
<list list-type="bullet"><list-item><p>Squamous cell carcinoma and other centrally located malignancies are either&#x000a0;vascular sources themselves or erode into nearby vessels.<xref ref-type="bibr" rid="article-28032.r2">[2]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Pneumonia</bold>
<list list-type="bullet"><list-item><p><italic toggle="yes">Staphylococcus aureus</italic> is among the most common pathogens. The production of Panton-Valentine Leukocidin (PVL) toxin in methicillin-susceptible <italic toggle="yes">Staphylococcus aureus</italic>&#x000a0;and methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic>&#x000a0;strains is linked to heightened bacterial virulence.<xref ref-type="bibr" rid="article-28032.r13">[13]</xref>&#x000a0;Pathogenicity of the PVL exotoxin is thought to be due to binding via a G protein-coupled membrane-bound receptor that causes neutrophil adhesion to endothelial cells, capillary dilation, leukocyte migration, and vascular necrosis.</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28032.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Differentiating between gastric and pulmonary sources of bleeding is essential. Asking the patient whether the bleeding is from vomiting or coughing can sometimes help differentiate. A pertinent history will include the amount of blood loss, onset, fevers, history of TB infection or travel to endemic areas, smoking history, cancer history, night sweats, weight loss, and history of anticoagulation use.&#x000a0;Asking about the patient's exertional status (ie, ability to climb stairs or walk distances) before the episode is also pertinent,&#x000a0;as it may&#x000a0;help determine&#x000a0;whether or not the patient can functionally tolerate a lobectomy if indicated.<xref ref-type="bibr" rid="article-28032.r14">[14]</xref></p>
        <p>The patient's initial evaluation includes an assessment of their airway, breathing, and circulation. Evaluate the patency of the airway and check the oropharynx for a proximal bleeding source. The bulk of the physical exam should focus on evaluating stability and ruling out any nonpulmonary source (eg, hematemesis or epistaxis).<xref ref-type="bibr" rid="article-28032.r2">[2]</xref> Capillary refill and skin evaluation can help decide if the patient needs an emergent transfusion of blood products. A lung exam may help determine if there is a unilateral source of the bleeding.</p>
        <p>The exact amount of blood loss in hemoptysis varies in the literature, ranging from 100 to 200 mL, making it difficult to measure accurately. Given that the anatomical dead space of an average adult is about 200 mL, a patient presenting with distress, tachypnea, and hypoxia alongside significant hemoptysis should prompt immediate resuscitation efforts. This clinical presentation should guide intervention rather than attempting to measure and quantify the precise amount of blood loss.</p>
      </sec>
      <sec id="article-28032.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A&#x000a0;complete blood count with differential should be drawn to evaluate the hemoglobin and hematocrit and assess for thrombocytopenia.&#x000a0;A basic metabolic panel, blood type, crossmatch, arterial blood gas, and coagulation panel should also be obtained. A frontal chest&#x000a0;x-ray (CXR)&#x000a0;should be obtained to find a unilateral source. CXR can determine the site of bleeding 45% to 65% of the time and the cause in 25% to 35%.<xref ref-type="bibr" rid="article-28032.r15">[15]</xref> If the patient is stable, a chest computed tomography (CT) scan can be considered to delineate the source and etiology. CT may be more sensitive than bronchoscopy; some sources consider it the first line in the evaluation.<xref ref-type="bibr" rid="article-28032.r16">[16]</xref><xref ref-type="bibr" rid="article-28032.r17">[17]</xref><xref ref-type="bibr" rid="article-28032.r18">[18]</xref><xref ref-type="bibr" rid="article-28032.r19">[19]</xref><xref ref-type="bibr" rid="article-28032.r20">[20]</xref></p>
      </sec>
      <sec id="article-28032.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Lung Isolation</bold>
</p>
        <p>If the chest radiograph shows a unilateral source of bleeding or a known source is elicited in the history and physical, place the affected side down to isolate bleeding and spare the remaining lung.<xref ref-type="bibr" rid="article-28032.r15">[15]</xref><xref ref-type="bibr" rid="article-28032.r21">[21]</xref>&#x000a0;Other simple maneuvers include putting the patient in the Trendelenburg or reverse Trendelenburg position to isolate the bleeding source further.<xref ref-type="bibr" rid="article-28032.r15">[15]</xref></p>
        <p>
<bold>Intubation</bold>
</p>
        <p>If the&#x000a0;decision is made to intubate, it is advisable to use at least an 8 mm endotracheal tube (ETT) to allow subsequent use of bronchoscopy and bronchial blockers. Direct laryngoscopy is generally preferred over video laryngoscopy when there is significant bleeding. Attaching a meconium aspirator to the ETT may help with visualization. If bleeding is uncontrolled, intubating the right main stem may be necessary. If the bleeding originates from the left side of the lung and no bronchoscope is available, place the patient in the right-lateral decubitus position to shift the mediastinum to the right.&#x000a0;</p>
        <p>In a study on 25 cadavers,&#x000a0;the intubating clinicians were able to&#x000a0;select the desired lung by first intubating the patient and then rotating the ETT 90&#x000b0; toward the desired side and advancing until resistance was met. This technique was successful 72.3% of the time for the left lung and 94% for the right lung.<xref ref-type="bibr" rid="article-28032.r22">[22]</xref> Suppose attempts to select the proper lung are unsuccessful. In that case, it may be possible to intubate the right main stem with a 5 mm ETT, allowing either ventilation of the right lung if it is unaffected or isolation of the right lung if it is hemorrhaging. If the right lung is the affected side, the 5 mm ETT should be small enough to allow the placement of another ETT to the left lung for ventilation. Approaches&#x000a0;like suction suction-assisted laryngoscopy and airway decontamination (SALAD), and double suction techniques have been developed to properly control the soiled airway.<xref ref-type="bibr" rid="article-28032.r23">[23]</xref></p>
        <p>
<bold>Anticoagulation Reversal</bold>
</p>
        <p>If the&#x000a0;patient is on anticoagulation, reversing any medication is paramount&#x000a0;in achieving hemostasis.</p>
        <p>
<bold>Tranexamic Acid&#x000a0;</bold>
</p>
        <p>With the success of the World Maternal Antifibrinolytic (WOMAN) and Clinical Randomisation of an Antifibrinolytic in Significant Hemorrhage 2 (CRASH-2) trials in postpartum hemorrhage and trauma, respectively, there have been some case reports of the use of&#x000a0;intravenous tranexamic acid (TXA) or nebulized TXA in pulmonary hemorrhage with some success.<xref ref-type="bibr" rid="article-28032.r21">[21]</xref>&#x000a0;Results from a recent&#x000a0;randomized controlled trial of 47 patients showed 96% resolution of hemoptysis in 5 days with inhaled TXA 500 mg&#x000a0;3 times a day versus the placebo group with 50%. Patients with hemoptysis greater than 200 mL in 24 hours or with hemodynamic or respiratory instability were excluded.<xref ref-type="bibr" rid="article-28032.r24">[24]</xref></p>
        <p>
<bold>Double-Lumen Endotracheal Tube</bold>
</p>
        <p>Double-lumen tubes are generally&#x000a0;not recommended for many reasons:</p>
        <list list-type="bullet">
          <list-item>
            <p>The bronchoscope used to place the double-lumen ETT does not have adequate suction channels to give clear visualization in the face of massive bleeding or the ability to suction out large clots.</p>
          </list-item>
          <list-item>
            <p>The double-lumen ETT only allows pediatric bronchoscopes and not therapeutic bronchoscopies.</p>
          </list-item>
          <list-item>
            <p>This ETT&#x000a0;does not allow evaluation of the proximal airways.</p>
          </list-item>
          <list-item>
            <p>Placement of the double-lumen ETT is more time-consuming and requires more expertise; this may be difficult to assemble during a crisis.<xref ref-type="bibr" rid="article-28032.r14">[14]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Bronchoscopy</bold>
</p>
        <p>Fiberoptic bronchoscopy allows for visualization of the source of bleeding, clearing the airway of bleeding and clots (especially in the nonbleeding lung). Visualizing the bleeding source is essential for later hemostatic techniques such as bronchial blocker placement. In large-scale bleeding,&#x000a0;fiberoptic bronchoscopy is often necessary for proper intubation of the nonbleeding lung and can be used to wedge into the bleeding site to create tamponade.</p>
        <p>Rigid bronchoscopy allows simultaneous evaluation of the bleeding source and ventilation of the nonbleeding lung. The large channels of this device can accommodate additional suction catheters and&#x000a0;fiberoptic bronchoscopy for visualizations. The rigid bronchoscope also allows users to use the full array of intrabronchial therapeutic techniques.</p>
        <p>
<bold>Bronchial Blocker</bold>
</p>
        <p>This device allows for the simultaneous ventilation of clear lungs while tamponading the bleeding side. A bronchial blocker&#x000a0;is usually inserted with the assistance of a&#x000a0;fiberoptic bronchoscope through an ETT, which enables the placement of a cuffed catheter that can tamponade the bleeding lung. The device is generally inserted into the main stem bronchus or bronchus intermedius, providing temporary hemostasis until further definitive treatment can be administered.<xref ref-type="bibr" rid="article-28032.r25">[25]</xref>&#x000a0;When a commercial device is unavailable, some clinicians have described the successful placement of a Fogarty catheter through the channel of a fiberoptic bronchoscope, which can also be introduced alongside the ETT.<xref ref-type="bibr" rid="article-28032.r21">[21]</xref></p>
        <p>
<bold>Intrabronchial Treatments</bold>
</p>
        <p>These include cold saline lavage, epinephrine injections, spigots, cellulose mesh, and&#x000a0;antidiuretic hormone&#x000a0;derivatives introduced through a&#x000a0;fiberoptic or rigid bronchoscope. If a definitive source of bleeding is present and reachable, electrocautery, cryotherapy, laser, or argon plasma coagulation is also an option.<xref ref-type="bibr" rid="article-28032.r14">[14]</xref> &#x000a0;</p>
        <p>
<bold>Bronchial&#x000a0;Artery Embolization </bold>
</p>
        <p>Bronchial artery embolization (BAE) is a definitive treatment for bleeding from the bronchial artery system, which accounts for approximately 90% of cases. BAE&#x000a0;is often considered the first line of management in massive pulmonary hemorrhage, with success rates reaching up to 90% in the right patient population.<xref ref-type="bibr" rid="article-28032.r26">[26]</xref><xref ref-type="bibr" rid="article-28032.r27">[27]</xref><xref ref-type="bibr" rid="article-28032.r28">[28]</xref> Active contrast extravasation is observed in only 10% to 15% of cases, so site selection typically relies on radiographic signs such as hypertortuosity, artery hypertrophy, aneurysms, or arteriovenous malformations.<xref ref-type="bibr" rid="article-28032.r26">[26]</xref><xref ref-type="bibr" rid="article-28032.r27">[27]</xref><xref ref-type="bibr" rid="article-28032.r29">[29]</xref> Suspected bleeding sources are embolized using microspheres, gelatin sponges, or coils. However, re-bleeding occurs in about 30% of patients within 30 days, making lobe resection a consideration for appropriate candidates.<xref ref-type="bibr" rid="article-28032.r27">[27]</xref> With current technology, the complication rate for anterior spinal artery embolization is as low as 0% to 1%.<xref ref-type="bibr" rid="article-28032.r15">[15]</xref></p>
        <p>
<bold>Surgery</bold>
</p>
        <p>Resection is considered the last resort for managing pulmonary hemorrhage due to its high mortality rates. According to a study by Adrejak et al, emergent resections have a mortality rate of 35%, which significantly decreases to 4% in resections scheduled after achieving hemostasis and 0% in planned resections after discharge.<xref ref-type="bibr" rid="article-28032.r30">[30]</xref> Therefore, providing temporary hemostasis, when possible, is prudent to avoid emergency resection. This approach allows for medical optimization of the patient and affords more time to thoroughly evaluate the necessary extent of resection.<xref ref-type="bibr" rid="article-28032.r14">[14]</xref></p>
      </sec>
      <sec id="article-28032.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The following diagnoses should be considered in cases of pulmonary hemorrhage:</p>
        <list list-type="bullet">
          <list-item>
            <p>Aspergilloma</p>
          </list-item>
          <list-item>
            <p>Alveolar hemorrhage</p>
          </list-item>
          <list-item>
            <p>Arteriovenous malformations</p>
          </list-item>
          <list-item>
            <p>Bronchitis</p>
          </list-item>
          <list-item>
            <p>Bronchiectasis</p>
          </list-item>
          <list-item>
            <p>Coagulopathy</p>
          </list-item>
          <list-item>
            <p>Emboli (pulmonary)</p>
          </list-item>
          <list-item>
            <p>Lung abscess</p>
          </list-item>
          <list-item>
            <p>Mitral stenosis</p>
          </list-item>
          <list-item>
            <p>Tuberculosis</p>
          </list-item>
          <list-item>
            <p>Tumor</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28032.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of pulmonary hemorrhage varies significantly based on the underlying cause, the severity of the bleeding, and the promptness and effectiveness of the treatment. Early recognition and intervention are critical to improving outcomes. Pulmonary hemorrhage, particularly when massive, is associated with high mortality rates, historically reaching up to 70% before the advent of BAE. The prognosis is generally favorable for patients with mild to moderate hemoptysis if the underlying cause can be effectively treated. Conditions like bronchiectasis, tuberculosis, and aspergilloma can be managed with appropriate medical or surgical interventions, leading to improved patient outcomes.</p>
        <p>The prognosis is more guarded in cases of massive hemoptysis. Prompt and effective management, including airway protection, hemostasis, and definitive treatment of the bleeding source, is crucial. Techniques such as BAE have significantly improved survival rates, with up to 90% success rates in appropriate patient populations. However, there is still a risk of rebleeding, which occurs in approximately 30% of patients within 30 days, necessitating close follow-up and sometimes further intervention.</p>
        <p>Overall, the prognosis of pulmonary hemorrhage depends on several factors, including the rapidity of intervention, the availability of advanced medical and surgical techniques, and the patient's overall health and comorbidities. With advances in medical technology and interdisciplinary care, patient outcomes with pulmonary hemorrhage continue to improve.&#x000a0;Developing&#x000a0;an interprofessional team to care for patients with hemoptysis is crucial to stratify cases, guide interventions, and determine the need for observation or hospital admission. Implementing such a&#x000a0;team would help optimize resource allocation, facilitate timely interventions, and improve patient outcomes by effectively managing the root cause and acute bleeding episodes.<xref ref-type="bibr" rid="article-28032.r7">[7]</xref></p>
      </sec>
      <sec id="article-28032.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of pulmonary hemorrhage can be severe and life-threatening, reflecting the critical nature of this condition. Here are the primary complications associated with pulmonary hemorrhage:</p>
        <list list-type="bullet">
          <list-item>
            <p>Respiratory failure
<list list-type="bullet"><list-item><p>The most immediate and severe complication is respiratory failure due to the obstruction of airways by blood; this can lead to hypoxia, hypercapnia, and acute respiratory distress syndrome.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Hemodynamic instability
<list list-type="bullet"><list-item><p>Massive pulmonary hemorrhage can lead to significant blood loss, resulting in hypovolemic shock.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Infection
<list list-type="bullet"><list-item><p>The presence of blood in the airways and lungs can breed infections, including pneumonia; this risk is increased in patients who require prolonged intubation and mechanical ventilation.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Rebleeding
<list list-type="bullet"><list-item><p>Even after initial control of hemorrhage, there is a substantial risk of rebleeding, particularly in patients with underlying conditions such as bronchiectasis or arteriovenous malformations.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Airway complications
<list list-type="bullet"><list-item><p>Intubation and bronchoscopic procedures carry risks, including airway trauma, bronchospasm, and mucosal injury.</p></list-item><list-item><p>Improper positioning of endotracheal tubes or bronchial blockers can exacerbate bleeding or fail to control it adequately.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Complications from interventions
<list list-type="bullet"><list-item><p>Procedures like BAE can lead to complications such as nontarget embolization, which may cause ischemia in nontarget areas, including the spinal cord, leading to paraplegia.</p></list-item><list-item><p>The risk is low but significant, necessitating careful procedural planning and execution.</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Cardiovascular complications
<list list-type="bullet"><list-item><p>Severe pulmonary hemorrhage can lead to right ventricular strain or failure due to increased pulmonary vascular resistance.&#x000a0;</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Neurological complications
<list list-type="bullet"><list-item><p>Severe hypoxia due to respiratory failure can lead to neurological damage, including hypoxic brain injury.&#x000a0;</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Mortality
<list list-type="bullet"><list-item><p>Despite advances in management, massive pulmonary hemorrhage remains associated with high mortality rates.&#x000a0;</p></list-item><list-item><p>The mortality rate&#x000a0;is low for patients with mild (2.5%) and moderate (6%) hemoptysis but high (38%) for those with massive hemoptysis.</p></list-item><list-item><p>Patients with lung cancer or bleeding diathesis experience higher mortality rates compared to the rest of the group.<xref ref-type="bibr" rid="article-28032.r31">[31]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
        <p>Managing pulmonary hemorrhage requires a multidisciplinary approach involving pulmonologists, intensivists, interventional radiologists, and thoracic surgeons to address these complications effectively and improve patient outcomes.</p>
      </sec>
      <sec id="article-28032.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Deterrence and patient education are crucial in managing pulmonary hemorrhage, given its potential severity and impact on patient well-being. Proactive measures can help prevent episodes of pulmonary hemorrhage, especially in high-risk individuals. These measures include regularly monitoring and managing underlying conditions such as bronchiectasis, tuberculosis, cystic fibrosis, and chronic bronchitis. Smoking cessation programs, vaccination against respiratory infections, and prompt treatment of respiratory infections can significantly reduce the risk of pulmonary complications. Additionally, patients with known risk factors for pulmonary hemorrhage should be educated on recognizing early signs and symptoms, ensuring they seek immediate medical attention to prevent severe outcomes.</p>
        <p>Patient education plays a vital role in the overall management of pulmonary hemorrhage. Since hemoptysis can be worrisome to patients and their families, reassurance and symptomatic and etiologic care are essential to improved outcomes.<xref ref-type="bibr" rid="article-28032.r15">[15]</xref> Patients should be informed about the potential causes of their symptoms and the importance of adhering to treatment plans for underlying conditions. Education should also cover the importance of follow-up appointments, medication adherence, and lifestyle modifications to reduce risk factors. By empowering patients with knowledge and providing reassurance, healthcare professionals can help alleviate anxiety, promote proactive health behaviors, and enhance the overall quality of life for patients at risk of pulmonary hemorrhage.</p>
      </sec>
      <sec id="article-28032.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Managing pulmonary hemorrhage requires a coordinated, multidisciplinary approach to enhance patient-centered care, outcomes, patient safety, and team performance. Physicians, advanced clinicians, nurses, pharmacists, and other healthcare professionals must collaboratively leverage their expertise and skills. Clinicians should be adept at rapid assessment and decision-making to stabilize the patient, including airway management and hemostasis techniques such as bronchial artery embolization. Nurses are critical in monitoring vital signs, administering medications, and providing continuous bedside care. Pharmacists can ensure the availability and proper use of necessary medications, such as anticoagulants or reversal agents, while also advising on drug interactions and side effects.</p>
        <p>Effective interprofessional communication and care coordination are essential for optimal outcomes in pulmonary hemorrhage management. Regular team meetings and clear communication channels facilitate timely information sharing and coordinated responses to patient needs. Utilizing standardized protocols and checklists can help ensure consistency in care delivery. Electronic health records can be instrumental in maintaining up-to-date patient information accessible to all team members, aiding in accurate and efficient care transitions. By fostering a culture of collaboration and continuous education, healthcare teams can improve patient safety, reduce complications, and enhance the overall quality of care for patients experiencing pulmonary hemorrhage.</p>
      </sec>
      <sec id="article-28032.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28032&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28032">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/lung-disease-respiratory-health/pulmonary-hemorrhage/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=28032">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28032/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28032">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-28032.s15">
        <title>References</title>
        <ref id="article-28032.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karlafti</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tsavdaris</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kotzakioulafi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kougias</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tagarakis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kaiafa</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Netta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Savopoulos</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Michalopoulos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Paramythiotis</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Which Is the Best Way to Treat Massive Hemoptysis? A Systematic Review and Meta-Analysis of Observational Studies.</article-title>
            <source>J Pers Med</source>
            <year>2023</year>
            <month>Nov</month>
            <day>26</day>
            <volume>13</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">38138876</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Radchenko</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Alraiyes</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Shojaee</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A systematic approach to the management of massive hemoptysis.</article-title>
            <source>J Thorac Dis</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>9</volume>
            <issue>Suppl 10</issue>
            <fpage>S1069</fpage>
            <page-range>S1069-S1086</page-range>
            <pub-id pub-id-type="pmid">29214066</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prey</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Francis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Krishnadasan</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Evaluation and Treatment of Massive Hemoptysis.</article-title>
            <source>Surg Clin North Am</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>102</volume>
            <issue>3</issue>
            <fpage>465</fpage>
            <page-range>465-481</page-range>
            <pub-id pub-id-type="pmid">35671767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fartoukh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Khoshnood</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Parrot</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Khalil</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carette</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Stoclin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mayaud</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cadranel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ancel</surname>
                <given-names>PY</given-names>
              </name>
            </person-group>
            <article-title>Early prediction of in-hospital mortality of patients with hemoptysis: an approach to defining severe hemoptysis.</article-title>
            <source>Respiration</source>
            <year>2012</year>
            <volume>83</volume>
            <issue>2</issue>
            <fpage>106</fpage>
            <page-range>106-14</page-range>
            <pub-id pub-id-type="pmid">22025193</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mondoni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carlucci</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Job</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Parazzini</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Cipolla</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pagani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tursi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Negri</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fois</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Canu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Arcadu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pirina</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bonifazi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gasparini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Comel</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Ravenna</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dore</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Alfano</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sferrazza Papa</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Di Marco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Centanni</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sotgiu</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Observational, multicentre study on the epidemiology of haemoptysis.</article-title>
            <source>Eur Respir J</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>51</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">29301924</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsoumakidou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chrysofakis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tsiligianni</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Maltezakis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Siafakas</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Tzanakis</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>A prospective analysis of 184 hemoptysis cases: diagnostic impact of chest X-ray, computed tomography, bronchoscopy.</article-title>
            <source>Respiration</source>
            <year>2006</year>
            <volume>73</volume>
            <issue>6</issue>
            <fpage>808</fpage>
            <page-range>808-14</page-range>
            <pub-id pub-id-type="pmid">16446530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singer</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Faiz</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Qdaisat</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abdeldaem</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dagher</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chaftari</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Yeung</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Hemoptysis in Cancer Patients.</article-title>
            <source>Cancers (Basel)</source>
            <year>2023</year>
            <month>Sep</month>
            <day>28</day>
            <volume>15</volume>
            <issue>19</issue>
            <pub-id pub-id-type="pmid">37835458</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cahill</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Ingbar</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Massive hemoptysis. Assessment and management.</article-title>
            <source>Clin Chest Med</source>
            <year>1994</year>
            <month>Mar</month>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>147</fpage>
            <page-range>147-67</page-range>
            <pub-id pub-id-type="pmid">8200191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zatakia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shojaee</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Calcified Lymph Node. An Unusual Cause of Hemoptysis.</article-title>
            <source>Ann Am Thorac Soc</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>12</volume>
            <issue>8</issue>
            <fpage>1240</fpage>
            <page-range>1240-2</page-range>
            <pub-id pub-id-type="pmid">26317274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rasmussen</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>WD</given-names>
              </name>
            </person-group>
            <article-title>On H&#x000e6;moptysis, Especially When Fatal, in Its Anatomical and Clinical Aspects.</article-title>
            <source>Edinb Med J</source>
            <year>1868</year>
            <month>Dec</month>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>486</fpage>
            <page-range>486-503</page-range>
            <pub-id pub-id-type="pmid">29639578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boulay</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Berthier</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sisteron</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Gendreike</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Blaive</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Seasonal variation in cryptogenic and noncryptogenic hemoptysis hospitalizations in France.</article-title>
            <source>Chest</source>
            <year>2000</year>
            <month>Aug</month>
            <volume>118</volume>
            <issue>2</issue>
            <fpage>440</fpage>
            <page-range>440-4</page-range>
            <pub-id pub-id-type="pmid">10936138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herth</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ernst</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>HD</given-names>
              </name>
            </person-group>
            <article-title>Long-term outcome and lung cancer incidence in patients with hemoptysis of unknown origin.</article-title>
            <source>Chest</source>
            <year>2001</year>
            <month>Nov</month>
            <volume>120</volume>
            <issue>5</issue>
            <fpage>1592</fpage>
            <page-range>1592-4</page-range>
            <pub-id pub-id-type="pmid">11713139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maucotel</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Kolenda</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Laurent</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tristan</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Staphylococcus aureus: No ticket for the Paris 2024 Olympic Games!</article-title>
            <source>Infect Dis Now</source>
            <year>2024</year>
            <month>Jun</month>
            <volume>54</volume>
            <issue>4S</issue>
            <fpage>104882</fpage>
            <pub-id pub-id-type="pmid">38849255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yendamuri</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Massive Airway Hemorrhage.</article-title>
            <source>Thorac Surg Clin</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>255</fpage>
            <page-range>255-60</page-range>
            <pub-id pub-id-type="pmid">26210922</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gagnon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Quigley</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dutau</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Delage</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fortin</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Approach to Hemoptysis in the Modern Era.</article-title>
            <source>Can Respir J</source>
            <year>2017</year>
            <volume>2017</volume>
            <fpage>1565030</fpage>
            <pub-id pub-id-type="pmid">29430203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dweik</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Stoller</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Role of bronchoscopy in massive hemoptysis.</article-title>
            <source>Clin Chest Med</source>
            <year>1999</year>
            <month>Mar</month>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>89</fpage>
            <page-range>89-105</page-range>
            <pub-id pub-id-type="pmid">10205720</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Revel</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Fournier</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Hennebicque</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Cuenod</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Reynaud</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Frija</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Can CT replace bronchoscopy in the detection of the site and cause of bleeding in patients with large or massive hemoptysis?</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>2002</year>
            <month>Nov</month>
            <volume>179</volume>
            <issue>5</issue>
            <fpage>1217</fpage>
            <page-range>1217-24</page-range>
            <pub-id pub-id-type="pmid">12388502</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Millar</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Boothroyd</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hetzel</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>The role of computed tomography (CT) in the investigation of unexplained haemoptysis.</article-title>
            <source>Respir Med</source>
            <year>1992</year>
            <month>Jan</month>
            <volume>86</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-44</page-range>
            <pub-id pub-id-type="pmid">1565816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Set</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Flower</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Twentyman</surname>
                <given-names>OP</given-names>
              </name>
              <name>
                <surname>Shneerson</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Hemoptysis: comparative study of the role of CT and fiberoptic bronchoscopy.</article-title>
            <source>Radiology</source>
            <year>1993</year>
            <month>Dec</month>
            <volume>189</volume>
            <issue>3</issue>
            <fpage>677</fpage>
            <page-range>677-80</page-range>
            <pub-id pub-id-type="pmid">8234690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khalil</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Soussan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mangiapan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fartoukh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Parrot</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Carette</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Utility of high-resolution chest CT scan in the emergency management of haemoptysis in the intensive care unit: severity, localization and aetiology.</article-title>
            <source>Br J Radiol</source>
            <year>2007</year>
            <month>Jan</month>
            <volume>80</volume>
            <issue>949</issue>
            <fpage>21</fpage>
            <page-range>21-5</page-range>
            <pub-id pub-id-type="pmid">16916805</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Solomonov</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fruchter</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Zuckerman</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Brenner</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Yigla</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary hemorrhage: A novel mode of therapy.</article-title>
            <source>Respir Med</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>103</volume>
            <issue>8</issue>
            <fpage>1196</fpage>
            <page-range>1196-200</page-range>
            <pub-id pub-id-type="pmid">19251406</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bair</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Doherty</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Harper</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Albertson</surname>
                <given-names>TE</given-names>
              </name>
            </person-group>
            <article-title>An evaluation of a blind rotational technique for selective mainstem intubation.</article-title>
            <source>Acad Emerg Med</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>11</volume>
            <issue>10</issue>
            <fpage>1105</fpage>
            <page-range>1105-7</page-range>
            <pub-id pub-id-type="pmid">15466157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kovacs</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sowers</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Airway Management in Trauma.</article-title>
            <source>Emerg Med Clin North Am</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>61</fpage>
            <page-range>61-84</page-range>
            <pub-id pub-id-type="pmid">29132582</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wand</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Guber</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Guber</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Epstein Shochet</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Israeli-Shani</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shitrit</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Inhaled Tranexamic Acid for Hemoptysis Treatment: A Randomized Controlled Trial.</article-title>
            <source>Chest</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>154</volume>
            <issue>6</issue>
            <fpage>1379</fpage>
            <page-range>1379-1384</page-range>
            <pub-id pub-id-type="pmid">30321510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garzon</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Gourin</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Surgical management of massive hemoptysis. A ten-year experience.</article-title>
            <source>Ann Surg</source>
            <year>1978</year>
            <month>Mar</month>
            <volume>187</volume>
            <issue>3</issue>
            <fpage>267</fpage>
            <page-range>267-71</page-range>
            <pub-id pub-id-type="pmid">637582</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>ZX</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>YW</given-names>
              </name>
              <name>
                <surname>She</surname>
                <given-names>DY</given-names>
              </name>
            </person-group>
            <article-title>Immediate and long-term results of bronchial artery embolization for hemoptysis due to benign versus malignant pulmonary diseases.</article-title>
            <source>Am J Med Sci</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>348</volume>
            <issue>3</issue>
            <fpage>204</fpage>
            <page-range>204-9</page-range>
            <pub-id pub-id-type="pmid">24556929</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fruchter</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Schneer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rusanov</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Belenky</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kramer</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Bronchial artery embolization for massive hemoptysis: long-term follow-up.</article-title>
            <source>Asian Cardiovasc Thorac Ann</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>55</fpage>
            <page-range>55-60</page-range>
            <pub-id pub-id-type="pmid">25053662</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaufman</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Kwan</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Bronchial Artery Embolization.</article-title>
            <source>Semin Intervent Radiol</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>39</volume>
            <issue>3</issue>
            <fpage>210</fpage>
            <page-range>210-217</page-range>
            <pub-id pub-id-type="pmid">36062235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fernando</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Benfield</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Link</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>Role of bronchial artery embolization in the management of hemoptysis.</article-title>
            <source>Arch Surg</source>
            <year>1998</year>
            <month>Aug</month>
            <volume>133</volume>
            <issue>8</issue>
            <fpage>862</fpage>
            <page-range>862-6</page-range>
            <pub-id pub-id-type="pmid">9711960</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andr&#x000e9;jak</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Parrot</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bazelly</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ancel</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Djibr&#x000e9;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Khalil</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grunenwald</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fartoukh</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Surgical lung resection for severe hemoptysis.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>88</volume>
            <issue>5</issue>
            <fpage>1556</fpage>
            <page-range>1556-65</page-range>
            <pub-id pub-id-type="pmid">19853112</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28032.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirshberg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Biran</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Glazer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kramer</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital.</article-title>
            <source>Chest</source>
            <year>1997</year>
            <month>Aug</month>
            <volume>112</volume>
            <issue>2</issue>
            <fpage>440</fpage>
            <page-range>440-4</page-range>
            <pub-id pub-id-type="pmid">9266882</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
